Magenta Therapeutics (MGTA) Q2 2023 Earnings

3AugConfirmed
Nov 22
Q4 2022
Q1 2023
Q2 2023
-0.34
-0.24
-0.15
-0.05

Details

Expected EPS
-0.19
Actual EPS
-0.05
Surprise EPS
0.14
Surprise Percent
+73.68%

Description

Magenta Therapeutics (MGTA) has reported earnings of -0.05 per share for Q2 2023.

0 Comments

Share your thoughts